大冷股份(000530.SZ):A股證券簡稱24日起由“大冷股份”變更為“冰山冷熱”
格隆匯3月23日丨大冷股份(000530.SZ)公佈,根據深交所相關規定,公司證券簡稱需來源於公司全稱,同時為了更好聚焦公司發展戰略,適應冷熱事業佈局,進一步加強品牌建設,提升冰山品牌價值,打造冷熱事業國際知名品牌,經公司申請,並經深交所核准,自2020年3月24日起,公司A股證券簡稱由“大冷股份”變更為“冰山冷熱”,B股證券簡稱由“大冷B”變更為“冰山B”。公司證券代碼不變。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.